Loading chat...

ND HB1053

Bill

Official Source

Status

Introduced

1/4/2011

Primary Sponsor

Unknown

Origin

House of Representatives

62nd Legislative Assembly

AI Summary

  • Creates section 65-02-20.1 of the North Dakota Century Code requiring organizations to pay for generic or bioequivalent controlled substances when available, unless use would produce a verifiable allergic reaction
  • Limits pharmaceutical payment to the cost of the generic or bioequivalent treatment
  • Disputes over generic drug requirements must be resolved using the same process as section 65-02-20
  • Director of workforce safety and insurance must prepare a report on "dispense as written" utilization information during the 2011-12 interim for presentation to legislative management
  • Applies to pharmaceutical treatments occurring on or after the effective date and expires July 31, 2013

Legislative Description

Workers' compensation benefits for generic drugs; to provide for a report; to provide for application; and to provide an expiration date.

Last Action

Second reading, failed to pass, yeas 7 nays 85

1/19/2011

Committee Referrals

Industry, Business, and Labor1/4/2011

Full Bill Text

No bill text available